El interés en corto de iSpecimen da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de iSpecimen. Los datos de interés en corto se actualizan cada dos semanas.

iSpecimen (NASDAQ:ISPC) Bolsa, Informe de interés en corto

iSpecimen

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

iSpecimen Inc

ISHARES PLC SHS ORD by IShares Plc.

<h3 class="wp-block-heading">Weed Is Not Legal In Florida But Medical Cannabis Retail Footprint Grows Nonetheless</h3>
RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/GTII#CSE">GTII</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTCQX">GTBIF</a>), opened RISE Dispensary Orlando on Good Homes Road on Friday, Nov. 8. Located at 725 Good Homes Road, the new West Orlando location expanded RISE Dispensaries' retail footprint in Florida to 21 locations and 99 nationwide.
Cannabis giant Curaleaf Holdings, Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CURA#TSX">CURA</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>) opened a new medical dispensary in Miami in October. Curaleaf Miami Bird Road, located at 8868 SW Bird Rd. in Miami, brought the company's Florida store count to 66 locations, with 151 dispensaries total nationwide.
Trulieve Cannabis Corp. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/TRUL#CSE">TRUL</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>), one of the biggest supporters of Amendment 3 which was rejected by Florida voters earlier this month and would have legalized recreational cannabis in the Sunshine State, additionally expanded its already substantial retail footprint statewide.
October store opening celebrations were held at:
<ul>
<li>Trulieve Bonita Springs South Tamiami, located at 28811 South Tamiami Trail, Unit 12, and Trulieve St. Augustine A1A, located at 3945 A1A South on Oct. 18;</li>
<li>Trulieve Orlando West Colonial, located at 7225 West Colonial Drive, Unit 100 on Oct. 25; and</li>
<li>Trulieve Lake Placid, located at 413 U.S. Highway 27, on Nov. 1.</li>
</ul>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">New Cannabis Stores In Six States And Canada</h3>
Illinois cannabis sales reached a major milestone in July, with sales surpassing $1 billion, as announced by Governor JB Pritzker‘s office. The burgeoning industry continues to grow by the day with new stores launching cannabis sales and events celebrating the plant. Stash Dispensaries recently announced the return of&nbsp;Sesh Haunted City, a special haunted house event to commemorate Sesh&#8217;s third anniversary.
C3 Industries, a multi-state cannabis company dedicated to crafting premium consumer experiences, recently opened High Profile Cannabis Shop Pineville at 35 Macadoodle Lane, its 9th retail location in Missouri and 29th nationwide.
Cannabis concept store Gotham held a grand opening event in October for its new Brooklyn, New York City location. The expansive 4,000-square-foot storefront is located in the heart of Williamsburg on Kent Avenue and South 2nd Street in The Refinery at Domino.
Sweetspot Farms, a new premium cannabis dispensary, is officially open at 111 High Ridge Rd. in Stamford, Connecticut, offering medical and recreational customers a modern and welcoming retail experience. Founded by two Stamford natives, Sweetspot aims to improve access to legal and regulated cannabis for qualified locals who depend on plant-based products for an improved quality of life.
SLO CAL Roots celebrated the grand opening of its third dispensary, Root One, in Guadalupe, California in October. Root One is the latest location from SLO CAL Roots, a Central Coast cannabis company founded in 2003 by local growers Austen Connella and Kristin Kordich.
Hashstoria, a cannabis dispensary co-founded by hip-hop icon Raekwon the Chef of Wu-Tang Clan fame, media personality Charlamagne Tha God, civil rights attorney Bakari Sellers and entrepreneur Jedd Canty hosted the official grand opening celebration in downtown Newark, New Jersey on Wednesday, Nov. 13. It's located at 799-805 Broad Street in the historic Four Corners district.
High Tide Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>) (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/HITI#TSXV">HITI</a>) (FSE: 2LYA) Canna Cabana retail cannabis store, located at 97 Bath Road, Kingston, Ontario, began selling recreational cannabis products and consumption accessories for adult use on Oct. 31. This opening marked the 186th Canna Cabana branded retail cannabis location in Canada, the 72nd in the province of Ontario, and the first in Kingston for the Canadian retail cannabis giant.

Cannabis

News

Entrepreneurship

Retail Sales

CSE:GTII

CSE:TRUL

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GTBIF

GTII

HITI

TCNNF

TRUL

TSX:CURA

TSXV:HITI

Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores

Needham analyst Laura Martin maintains Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Buy and raises the price target from $110 to $130.

Price Target

Analyst Ratings

Needham Maintains Buy on Walt Disney, Raises Price Target to $130

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Compass Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPX#NASDAQ">CMPX</a>) with a Buy and maintains $10 price target.

Reiteration

CMPX

HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $10 Price Target

HC Wainwright &amp; Co. analyst Ed Arce reiterates Sagimet Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMT#NASDAQ">SGMT</a>) with a Buy and maintains $32 price target.

SGMT

HC Wainwright & Co. Reiterates Buy on Sagimet Biosciences, Maintains $32 Price Target

HC Wainwright &amp; Co. analyst Yi Chen reiterates Kala Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALA#NASDAQ">KALA</a>) with a Buy and maintains $15 price target.

KALA

HC Wainwright & Co. Reiterates Buy on Kala Bio, Maintains $15 Price Target

Keurig Dr Pepper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) has outperformed the market over the past 15 years by 2.32% on an annualized basis producing an average annual return of 14.04%. Currently, Keurig Dr Pepper has a market capitalization of $45.06 billion. 
Buying $1000 In KDP: If an investor had bought $1000 of KDP stock 15 years ago, it would be worth $7,196.06 today based on a price of $33.22 for KDP at the time of writing.
<h3>Keurig Dr Pepper's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699205_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Keurig Dr Pepper 15 Years Ago Would Be Worth This Much Today

HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) has outperformed the market over the past 10 years by 6.46% on an annualized basis producing an average annual return of 17.48%. Currently, HCA Healthcare has a market capitalization of $87.70 billion. 
Buying $100 In HCA: If an investor had bought $100 of HCA stock 10 years ago, it would be worth $506.91 today based on a price of $339.83 for HCA at the time of writing.
<h3>HCA Healthcare's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699201_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today

Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) has outperformed the market over the past 10 years by 18.87% on an annualized basis producing an average annual return of 29.89%. Currently, Fabrinet has a market capitalization of $9.04 billion. 
Buying $1000 In FN: If an investor had bought $1000 of FN stock 10 years ago, it would be worth $13,993.98 today based on a price of $249.31 for FN at the time of writing.
<h3>Fabrinet's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699196_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Fabrinet Stock In The Last 10 Years

First Citizens BancShares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) has outperformed the market over the past 20 years by 6.83% on an annualized basis producing an average annual return of 15.15%. Currently, First Citizens BancShares has a market capitalization of $30.11 billion. 
Buying $100 In FCNCA: If an investor had bought $100 of FCNCA stock 20 years ago, it would be worth $1,728.18 today based on a price of $2152.02 for FCNCA at the time of writing.
<h3>First Citizens BancShares's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699191_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FCNCA

If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,700 Today

HC Wainwright &amp; Co. analyst Edward White reiterates 60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) with a Neutral.

SXTP

HC Wainwright & Co. Reiterates Neutral on 60 Degrees

Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) has outperformed the market over the past 15 years by 1.85% on an annualized basis producing an average annual return of 13.57%. Currently, Johnson Controls Intl has a market capitalization of $56.41 billion. 
Buying $100 In JCI: If an investor had bought $100 of JCI stock 15 years ago, it would be worth $684.45 today based on a price of $84.45 for JCI at the time of writing.
<h3>Johnson Controls Intl's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699187_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Johnson Controls Intl 15 Years Ago Would Be Worth This Much Today

Crown Castle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) has outperformed the market over the past 20 years by 1.26% on an annualized basis producing an average annual return of 9.59%. Currently, Crown Castle has a market capitalization of $44.95 billion. 
Buying $1000 In CCI: If an investor had bought $1000 of CCI stock 20 years ago, it would be worth $6,268.48 today based on a price of $103.43 for CCI at the time of writing.
<h3>Crown Castle's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699182_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Crown Castle Stock In The Last 20 Years

Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) has outperformed the market over the past 20 years by 2.84% on an annualized basis producing an average annual return of 11.16%. Currently, Texas Instruments has a market capitalization of $184.14 billion. 
Buying $100 In TXN: If an investor had bought $100 of TXN stock 20 years ago, it would be worth $822.22 today based on a price of $201.85 for TXN at the time of writing.
<h3>Texas Instruments's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699176_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Texas Instruments 20 Years Ago Would Be Worth This Much Today

Comfort Systems USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) has outperformed the market over the past 15 years by 15.86% on an annualized basis producing an average annual return of 27.59%. Currently, Comfort Systems USA has a market capitalization of $15.82 billion. 
Buying $1000 In FIX: If an investor had bought $1000 of FIX stock 15 years ago, it would be worth $40,251.81 today based on a price of $444.38 for FIX at the time of writing.
<h3>Comfort Systems USA's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699171_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Comfort Systems USA 15 Years Ago Would Be Worth Today

CRH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>) has outperformed the market over the past 5 years by 8.02% on an annualized basis producing an average annual return of 21.4%. Currently, CRH has a market capitalization of $66.88 billion. 
Buying $1000 In CRH: If an investor had bought $1000 of CRH stock 5 years ago, it would be worth $2,673.92 today based on a price of $98.52 for CRH at the time of writing.
<h3>CRH's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699167_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,700 Today

W.W. Grainger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>) has outperformed the market over the past 15 years by 6.27% on an annualized basis producing an average annual return of 17.99%. Currently, W.W. Grainger has a market capitalization of $57.42 billion. 
Buying $100 In GWW: If an investor had bought $100 of GWW stock 15 years ago, it would be worth $1,209.17 today based on a price of $1176.01 for GWW at the time of writing.
<h3>W.W. Grainger's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699162_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,200 Today

Investors with a lot of money to spend have taken a bullish stance on KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with KLAC, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 19 uncommon options trades for KLA.
This isn't normal.
The overall sentiment of these big-money traders is split between 52% bullish and 36%, bearish.
Out of all of the special options we uncovered, 13 are puts, for a total amount of $635,864, and 6 are calls, for a total amount of $411,004.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $500.0 to $770.0 for KLA over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for KLA's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across KLA's significant trades, within a strike price range of $500.0 to $770.0, over the past month.
<h3>KLA Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699125_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>KLAC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$66.0</td>
<td>$64.9</td>
<td>$66.0</td>
<td>$650.00</td>
<td>$237.6K</td>
<td align="right">4</td>
<td align="right">36</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$49.0</td>
<td>$44.0</td>
<td>$44.0</td>
<td>$670.00</td>
<td>$88.0K</td>
<td align="right">264</td>
<td align="right">21</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$30.2</td>
<td>$27.5</td>
<td>$28.8</td>
<td>$630.00</td>
<td>$83.2K</td>
<td align="right">117</td>
<td align="right">60</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$17.7</td>
<td>$15.1</td>
<td>$17.8</td>
<td>$640.00</td>
<td>$70.8K</td>
<td align="right">984</td>
<td align="right">157</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$31.6</td>
<td>$27.8</td>
<td>$29.7</td>
<td>$630.00</td>
<td>$62.3K</td>
<td align="right">117</td>
<td align="right">28</td>
</tr>
</tbody>
</table>

<h3>About KLA</h3>
KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market. It counts as top customers the largest chipmakers in the world, including TSMC and Samsung.
Following our analysis of the options activities associated with KLA, we pivot to a closer look at the company's own performance.
<h3>KLA's Current Market Status</h3>
<ul>
<li>With a volume of 823,831, the price of KLAC is down -4.03% at $619.0. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 69 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for KLA with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

KLAC

A Closer Look at KLA's Options Market Dynamics

Investors with a lot of money to spend have taken a bullish stance on Alcoa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AA, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 11 options trades for Alcoa.
This isn't normal.
The overall sentiment of these big-money traders is split between 72% bullish and 18%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $27,590, and 10, calls, for a total amount of $360,648.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $30.0 to $50.0 for Alcoa over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Alcoa stands at 4479.5, with a total volume reaching 29,752.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Alcoa, situated within the strike price corridor from $30.0 to $50.0, throughout the last 30 days.
<h3>Alcoa Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699120_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$17.75</td>
<td>$17.65</td>
<td>$17.75</td>
<td>$30.00</td>
<td>$65.6K</td>
<td>1.1K</td>
<td>0</td>
</tr>
<tr>
<td>AA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.84</td>
<td>$1.77</td>
<td>$1.82</td>
<td>$50.00</td>
<td>$58.2K</td>
<td>14.7K</td>
<td>352</td>
</tr>
<tr>
<td>AA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$5.8</td>
<td>$5.75</td>
<td>$5.8</td>
<td>$40.00</td>
<td>$36.5K</td>
<td>3.9K</td>
<td>1.5K</td>
</tr>
<tr>
<td>AA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$0.5</td>
<td>$0.49</td>
<td>$0.5</td>
<td>$44.50</td>
<td>$34.4K</td>
<td>580</td>
<td>9.0K</td>
</tr>
<tr>
<td>AA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$6.15</td>
<td>$6.05</td>
<td>$6.1</td>
<td>$40.00</td>
<td>$31.1K</td>
<td>3.9K</td>
<td>1.4K</td>
</tr>
</tbody>
</table>

<h3>About Alcoa</h3>
Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is the world's largest bauxite miner and alumina refiner by production volume, and the eighth-largest aluminum producer. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024, meaning refining assets are now predominantly wholly owned, as with smelting.
<h3>Alcoa's Current Market Status</h3>
<ul>
<li>With a trading volume of 8,829,143, the price of AA is up by 7.13%, reaching $44.15.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 61 days from now.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Alcoa with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Alcoa Unusual Options Activity For November 15

Deep-pocketed investors have adopted a bullish approach towards Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in WDAY usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Workday. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 2 are puts, totaling $307,567, and 6 are calls, amounting to $303,662.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $200.0 and $300.0 for Workday, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Workday's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Workday's whale activity within a strike price range from $200.0 to $300.0 in the last 30 days. 
<h3>Workday Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699115_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>WDAY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$14.5</td>
<td>$14.4</td>
<td>$14.5</td>
<td>$260.00</td>
<td>$259.5K</td>
<td>302</td>
<td align="right">182</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$101.2</td>
<td>$97.0</td>
<td>$99.7</td>
<td>$200.00</td>
<td>$99.7K</td>
<td>7</td>
<td align="right">15</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$18.5</td>
<td>$18.2</td>
<td>$18.2</td>
<td>$260.00</td>
<td>$63.7K</td>
<td>2.0K</td>
<td align="right">58</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$101.6</td>
<td>$100.0</td>
<td>$100.0</td>
<td>$200.00</td>
<td>$50.0K</td>
<td>7</td>
<td align="right">0</td>
</tr>
<tr>
<td>WDAY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$40.9</td>
<td>$40.0</td>
<td>$40.0</td>
<td>$280.00</td>
<td>$48.0K</td>
<td>2</td>
<td align="right">12</td>
</tr>
</tbody>
</table>

<h3>About Workday</h3>
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 18,000 employees.
<h3>Where Is Workday Standing Right Now?</h3>
<ul>
<li>With a volume of 1,151,193, the price of WDAY is down -4.12% at $260.31. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 11 days.</li>
</ul>
<h3>Professional Analyst Ratings for Workday</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $270.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Loop Capital keeps a Hold rating on Workday with a target price of $270. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Workday with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

WDAY

Looking At Workday's Recent Unusual Options Activity

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLN#NASDAQ">SLN</a>) with a Buy and maintains $75 price target.

HC Wainwright & Co. Reiterates Buy on Silence Therapeutics, Maintains $75 Price Target

The latest update is out from iSpecimen ( ($ISPC) ). iSpecimen Inc. has announced a 1-for-20 reverse stock split effective after market close on Se...

iSpecimen Announces Reverse Stock Split for Compliance and Appeal

These are the upcoming stock splits for the week of September 16 to September 20, based on&nbsp;TipRanks' Stock Splits Calendar. A stock split is a...

Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested

The latest announcement is out from iSpecimen ( ($ISPC) ). iSpecimen Inc. has secured a $1,000,000 loan from a lender, repayable within 12 months a...

iSpecimen Bolsters Finance with Loan and Board Revamp

iSpecimen ( ($ISPC) ) has issued an announcement. Benjamin Bielak, former Chief Information Officer of iSpecimen Inc., filed an arbitration demand ...

iSpecimen Faces Ex-Executive's Financial Claims, Regains Nasdaq Compliance

iSpecimen files to sell 1.2M shares of common stock

iSpecimen prices $5M public offering of common stock and warrants

iSpecimen ( ($ISPC) ) has issued an announcement. iSpecimen Inc. has announced a public offering of approximately $5 million in common stock and pr...

iSpecimen Announces Public Offering to Support Growth

iSpecimen (ISPC) announced a significant enhancement to its searchable inventory that provides researchers with increased access to a wide array of...

iSpecimen releases cancer biospecimen offering

Ispecimen Inc ( ($ISPC) ) has released its Q3 earnings. Here is a breakdown of the information Ispecimen Inc presented to its investors. iSpecimen ...

Comments

iSpecimen

Interés en corto

iSpecimen (NASDAQ:ISPC) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL